Schlemmer M, Wendtner C M, Issels R D
Department of Internal Medicine III, Klinikum Grosshadern Medical Center, Ludwig Maximilians University Munich, Munich, Germany.
Oncology. 2003;65 Suppl 2:76-9. doi: 10.1159/000073365.
For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improve outcome with regard to local control and overall survival. Therefore, systemic chemotherapy has been integrated either after (adjuvant) or before (neoadjuvant) optimal local treatment by surgery and radiotherapy in HR-STS. The combination with regional hyperthermia as a new treatment strategy seems to open a new therapeutic window.
对于成人高危软组织肉瘤(HR-STS),需要新的治疗策略来改善局部控制和总生存方面的结局。因此,在HR-STS中,全身化疗已被纳入到通过手术和放疗进行的最佳局部治疗之后(辅助治疗)或之前(新辅助治疗)。与区域热疗联合作为一种新的治疗策略似乎打开了一个新的治疗窗口。